SCHEMBL8287526

SCHEMBL8287526

O=C(c1ccccc1)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 3/20 0.38
MAPK12 P53778 3/20 0.38
MAPK11 Q15759 3/20 0.38
MAPK14 Q16539 3/20 0.38
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GSK3B P49841 5/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND2 P30279 1/20 0.35
CCND3 P30281 1/20 0.35
ABL1 P00519 1/20 0.35
SRC P12931 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA1 P30542 1/20 0.35
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34
PDE11A Q9HCR9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287593 0.90 GSK3B (0.37) MAPTNPC1RAB9ASMN1; SMN2GSK3B
SCHEMBL8287205 0.89 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286468 0.88 GSK3B (0.38) MAPTNPC1RAB9ASMN1; SMN2GSK3B
SCHEMBL8286472 0.87 EGFR (0.46) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL8286489 0.86 ALDH1A1 (0.36) MAPTNPC1RAB9ASMN1; SMN2GAA
SCHEMBL8287920 0.85 CSF1R (0.37) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL8362924 0.85 GSK3B (0.39) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL8287968 0.84 RIPK1 (0.41) MAPK14MAPTNPC1RAB9AHTT
SCHEMBL8285291 0.84 GABRA1 (0.40) MAPTNPC1RAB9ASMN1; SMN2GSK3B
SCHEMBL8287936 0.83 RIPK1 (0.40) GSK3BPDE11AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed